FindMyKOL
Clinical trialNCT06129253RecruitingObservational

Global Burden Estimation of Human Papillomavirus (GLOBE-HPV)

SponsorInternational Vaccine InstituteEnrollment29,750HPV Infection
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This study is a multi-country and multi-site project to estimate the point-prevalence of high-risk (HR) HPV genotype infections among representative samples of girls and women aged 9-50 years, and among specific sub-populations to estimate the incidence of persistent HPV infection among sexually active young women. The data to fulfill the objectives will be collected through a series of Cross-Sectional Surveys (CSS) and Longitudinal Studies (LS) in all 8 countries 3 South Asian countries including Bangladesh, Pakistan, Nepal and 5 sub-Saharan African countries including Sierra Leone, Tanzania, Ghana, Zambia and DR Congo. Qualitative sub-studies (QS) will be conducted in selected countries and populations following the CSS to further understand and unpack risk factors for HPV infection as well as to explore how gender-related dynamics including perceptions of gender norms and stigma, influence HPV burden and/or create barriers that shape girls/women access to and uptake of HPV prevention, screening, and treatment services. Specific study protocols and corresponding ethical applications for the qualitative sub-studies will be developed separately.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Bangladesh
  • Diarrhoeal Disease Research, Bangladesh (icddr,b)

    Dhaka, Bangladesh

    Completed
Democratic Republic of the Congo
  • Institut National Pour la Recherche Biomedicale (inrb)

    Kinshasa, Democratic Republic of the Congo

    Hugo Kavunga
    Recruiting
Ghana
  • University of Health and Allied Sciences (uhas)

    Ho, Volta Region, Ghana

    Completed
Nepal
  • Dhulikhel Hospital Kathmandu University Hospital (dhkuh)

    Dhulikhel, Nepal

    Completed
Pakistan
  • Aga Khan University (aku)

    Karachi, Pakistan

    Completed
Sierra Leone
  • College of Medicine and Allied Health Sciences (comahs)

    Freetown, Sierra Leone

    Completed
Tanzania
  • Mwanza Intervention Trial Unit (mitu)

    Mwanza, Tanzania

    Completed
Zambia
  • Zambart

    Lusaka, Zambia

    Completed

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
23 Nov 2023
Primary completion
31 Dec 2027
Completion
31 Dec 2027
Last update posted
16 Jul 2025
Registered enrollment
29,750
Registry id
NCT06129253

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.